首页> 美国卫生研究院文献>Gut >Improved symptom relief and duodenal ulcer healing with lansoprazole a new proton pump inhibitor compared with ranitidine.
【2h】

Improved symptom relief and duodenal ulcer healing with lansoprazole a new proton pump inhibitor compared with ranitidine.

机译:与雷尼替丁相比新型质子泵抑制剂兰索拉唑可改善症状缓解和十二指肠溃疡愈合。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study was to compare duodenal ulcer healing, symptom relief, and safety of lansoprazole (a new proton pump inhibitor) given at doses of 30 mg and 60 mg, in the morning with ranitidine 300 mg at bedtime. Two hundred and eighty nine patients were enrolled over a 20 month period in a double blind randomised parallel group comparative study set in outpatient endoscopy units of six United Kingdom medical centres. Patients were randomised to receive lansoprazole 30 mg in the morning (n = 95), 60 mg in the morning (n = 96), or ranitidine 300 mg at bedtime (n = 98) for four weeks. Efficacy was assessed by gastroscopy at study entry and after two and four weeks of treatment. Symptom relief was monitored by patient diaries and physician review at two and four weeks. Both doses of lansoprazole resulted in significantly greater ulcer healing than ranitidine after two and four weeks. Respective healing rates on lansoprazole 30 mg, 60 mg, and ranitidine 300 mg were 78%, 80%, and 60% after two weeks and 93%, 97%, and 81% after four weeks. Patients on lansoprazole 30 mg (p = 0.002) and lansoprazole 60 mg (p = 0.026) also recorded greater relief of night time pain in the diary cards during the first seven days of treatment than those on ranitidine. Patients on lansoprazole 60 mg reported significantly better pain relief at their two week visit compared with those receiving ranitidine (p = 0.007). There were no differences between treatment groups in the occurrence or pattern of adverse drug reactions during the trial. It is concluded that for patients with duodenal ulcer, lansoprazole 30 mg or 60 mg is associated with faster ulcer healing and better symptom relief than ranitidine 300 mg at bedtime. There were no significant differences between lansoprazole 30 mg and 60 mg. These data indicate that lansoprazole should be used at a once daily dose of 30 mg for the treatment of duodenal ulcer.
机译:这项研究的目的是比较兰索拉唑(一种新的质子泵抑制剂)在早晨与雷尼替丁300毫克就寝时给予十二指肠溃疡的愈合,症状缓解和安全性。在20个月的时间里,有289名患者参加了在英国6个医疗中心的门诊内窥镜检查单元中进行的双盲随机平行组比较研究。患者被随机分配接受兰索拉唑30毫克,上午(n = 95),早上60毫克(n = 96),或雷尼替丁300毫克就寝时间(n = 98),持续四周。在研究开始时以及治疗两,四个星期后通过胃镜检查评估疗效。在第2和第4周通过患者日记和医师复查监测症状缓解。两周和四周后,两种剂量的兰索拉唑均比雷尼替丁产生明显更大的溃疡愈合。兰索拉唑30 mg,60 mg和雷尼替丁300 mg的分别治愈率在两周后分别为78%,80%和60%,在四周后分别为93%,97%和81%。服用兰索拉唑30 mg(p = 0.002)和兰索拉唑60 mg(p = 0.026)的患者在治疗的前7天中,与使用雷尼替丁相比,在日记卡中记录到的夜间疼痛缓解也更大。与接受雷尼替丁治疗的患者相比,接受兰索拉唑60 mg治疗的患者在两周访视时疼痛明显改善(p = 0.007)。在试验期间,治疗组之间药物不良反应的发生或模式没有差异。结论是,对于十二指肠溃疡患者,兰索拉唑30 mg或60 mg在就寝时间比雷尼替丁300 mg具有更快的溃疡愈合和更好的症状缓解能力。兰索拉唑30 mg和60 mg之间无显着差异。这些数据表明兰索拉唑应以每日一次30 mg的剂量用于治疗十二指肠溃疡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号